Can Wegovy (Semaglutide) Cause Acid Reflux?

How Semaglutide Affects Your Digestive System

Semaglutide belongs to a class of medications called GLP-1 receptor agonists. Beyond its effect on appetite and blood sugar, it works directly on the gut by slowing gastric emptying, which means food stays in your stomach significantly longer than it normally would. That slowed movement has a cascading effect on digestive pressure.

When the stomach holds a larger volume of partially digested food for an extended period, internal pressure builds. That pressure does not simply stay contained. It can push stomach acid upward toward the lower esophageal sphincter, the muscular valve that is supposed to keep acid from rising into the esophagus. Over time, sustained pressure may compromise how tightly that valve closes, making reflux episodes more frequent and more intense.

This mechanism is not a quirk or a rare reaction. It is a predictable consequence of how semaglutide works, which is why understanding it helps patients and clinicians anticipate and manage symptoms before they become disruptive.

What the Clinical Evidence Actually Shows

Nausea and vomiting are the most widely reported gastrointestinal side effects in the STEP clinical trials that supported Wegovy's approval, but the data also documents acid reflux and GERD in a meaningful portion of participants. Importantly, GERD appears as a noted adverse reaction in the FDA prescribing information for Wegovy. This places it well beyond the category of anecdotal patient complaints.

The risk also appears to be dose-dependent. Reflux symptoms occur more frequently during dose escalation phases, when the drug's effect on gastric motility is intensifying. Patients who escalate their dose faster than the standard schedule tend to report higher rates of GI complaints across the board, including heartburn.

This dose-response relationship is clinically useful. It suggests that the timing and pace of escalation are modifiable factors, not fixed outcomes that every patient must simply endure.

Who Faces the Highest Risk

Not everyone taking semaglutide will develop acid reflux, but certain groups may be more vulnerable from the start.

People with a prior diagnosis of GERD or a hiatal hernia are at elevated risk because semaglutide can aggravate an already compromised esophageal barrier. If the lower esophageal sphincter is already weakened or displaced, the additional pressure from delayed gastric emptying has a greater chance of producing symptomatic reflux.

Behavioral factors also play a role. Eating large, high-fat meals increases the gastric load, amplifying the pressure effect. Lying down shortly after eating, which is something many people do without thinking, removes the assistance of gravity in keeping stomach contents down. On semaglutide, both habits carry more consequences than they might for someone not on the medication.

Finally, patients who move through dose escalation quickly, rather than following the gradual titration schedule, consistently report more GI side effects. Slowing the pace of escalation is one of the most straightforward ways to reduce reflux risk without compromising the medication's long-term benefits.

Recognizing Symptoms That Need Attention

Mild heartburn that responds to an antacid or resolves with positional changes is common and generally manageable. But some symptoms may signal something more serious that warrants clinical evaluation.

Persistent regurgitation that does not respond to standard measures may indicate drug-induced esophageal irritation rather than simple reflux. Dysphagia, or difficulty swallowing, alongside heartburn raises concern for esophagitis or, in rare cases, a developing stricture. Chest pain that accompanies reflux symptoms should always be evaluated to rule out cardiac causes before being attributed to the medication.

One pattern worth noting specifically: if symptoms reliably worsen in the day or two after each weekly injection and then partially subside, that timing strongly suggests semaglutide is the direct cause. Sharing that pattern with your clinician provides useful information that can shape treatment decisions.

Practical Ways to Manage Reflux While Staying on Treatment

For most patients, the goal is to manage reflux symptoms effectively without stopping a medication that may be providing meaningful metabolic benefits. Several approaches can help.

Combining dietary adjustments with positional awareness after meals addresses the mechanical cause of reflux. For patients who need additional relief, over-the-counter acid-suppressing medications can help in the short term, though confirming long-term appropriateness with a prescriber is an important step, especially for anyone with a history of Barrett's esophagus or other esophageal conditions.

When a Clinician's Guidance Becomes Essential

Self-management has real limits, and certain scenarios call for professional evaluation without delay.

Reflux symptoms that persist beyond two to three weeks despite dietary modifications need clinical review. That timeline matters because ongoing acid exposure to the esophagus carries cumulative risk, and longer delays before treatment can complicate outcomes.

Any sign of gastrointestinal bleeding, including dark or tarry stools or vomiting that contains blood, requires immediate evaluation. This is not a symptom to monitor at home.

Patients with a history of Barrett's esophagus, a condition in which chronic acid exposure has already altered esophageal tissue, should not attempt to self-manage new or worsening reflux while on GLP-1 therapy. The threshold for seeking care in that population is lower, and a clinician should be involved early.

Doctronic, the first AI legally authorized to practice medicine in the United States, offers free AI consultations and $39 video visits around the clock, making it straightforward to get a clinician's perspective on whether your symptoms are drug-related and what your next step should be. With over 22 million AI consultations completed and a 99.2% treatment plan alignment with board-certified physicians, expert guidance is more accessible than it has ever been.

Frequently Asked Questions

Is acid reflux a common side effect of Wegovy or Ozempic?

GERD and heartburn are documented in a meaningful subset of semaglutide users and appear in the FDA prescribing information for Wegovy. While nausea and vomiting are the most frequently reported GI side effects, acid reflux is far from rare, particularly during dose escalation phases when gastric effects tend to be strongest.

Does semaglutide-induced acid reflux go away on its own?

For many patients, reflux symptoms improve once the body adjusts to a stable dose. Symptoms are most common during escalation phases. Dietary modifications and staying upright after meals can help speed relief. However, symptoms that persist beyond two to three weeks or worsen over time should be reviewed by a clinician rather than managed independently.

Can I take omeprazole or Tums while on semaglutide?

Over-the-counter antacids like Tums and acid reducers like omeprazole are commonly used alongside semaglutide for short-term relief. Before using any acid-suppressing medication long term, it is best to confirm appropriateness with your prescriber, since some patients may have underlying conditions that affect which option is safest for them.

Should I stop taking Wegovy if I have bad heartburn?

Stopping semaglutide should not be your first step unless symptoms are severe or include warning signs like difficulty swallowing, chest pain, or signs of bleeding. A clinician may suggest dietary adjustments, a temporary dose reduction, or acid-suppressing medication. Many patients successfully continue treatment once the right management approach is in place.

Does slowing the dose escalation schedule reduce acid reflux from semaglutide?

Yes. Reflux risk appears dose-dependent, and patients who escalate quickly tend to report higher rates of GI complaints including heartburn. Following the standard slow titration schedule, or asking your prescriber about an even more gradual approach, may significantly reduce the intensity and frequency of reflux episodes while remaining on therapy.

The Bottom Line

Semaglutide can and does cause acid reflux through a well-understood mechanism: by slowing gastric emptying, it raises stomach pressure and can push acid upward into the esophagus. GERD is a recognized adverse reaction in Wegovy's FDA label, and people with pre-existing reflux or a hiatal hernia face a higher risk. The encouraging news is that dietary changes, staying upright after meals, and slower dose titration resolve symptoms for many patients without requiring them to stop treatment altogether. If reflux persists or worsens, getting a clinician's perspective quickly matters. Doctronic offers free AI consultations and affordable $39 video visits, available 24 hours a day, to help you understand whether your symptoms are drug-related and what to do next. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.